Glycopeptides from brain inhibit rates of polypeptide chain elongation.
In previous reports, we have identified cell-surface glycopeptides from mouse cerebrum (BCSG) that inhibited protein synthesis and mitosis in several cell types. When baby hamster kidney (BHK)-21 cells were infected with vesicular stomatitis virus (a negative strand RNA virus), BCSG extensively inhibited viral protein synthesis. This inhibition was effective against both protein and glycoprotein synthesis and was independent of amino acid uptake by infected cells, synthesis of viral RNA, and degradation of viral proteins. Analysis of polyribosome profiles in uninfected BHK-21 cells indicated that the degree of cellular protein synthesis inhibition could not be attributed to activation of RNase or solely to a disruption of chain initiation. When added directly to a cell-free protein-synthesizing system derived from BHK-21 cells, BCSG was ineffective, but if the inhibitory material was first allowed to react with cells, cell-free protein synthesis was substantially reduced. When BCSG were reacted with cells for 5 min at 0 degrees C, the cells tested, BHK-21 (a BCSG-sensitive line) and murine fibrosarcoma 2237 (a BCSG-insensitive line), both effectively adsorbed the inhibitor from the medium.
D000818:Animals; D001923:Brain Chemistry; D002460:Cell Line; D002474:Cell-Free System; D006224:Cricetinae; D003864:Depression, Chemical; D005354:Fibrosarcoma; D006020:Glycopeptides / Q000494:pharmacology*; D007668:Kidney; D008565:Membrane Proteins / Q000494:pharmacology*; D051379:Mice; D009419:Nerve Tissue Proteins / Q000494:pharmacology*; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects*; D011132:Polyribosomes / Q000187:drug effects / Q000378:metabolism; D014176:Protein Biosynthesis; D014721:Vesicular stomatitis Indiana virus / Q000254:growth & development / Q000378:metabolism; D014764:Viral Proteins / Q000096:biosynthesis
D006020:Glycopeptides; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D014764:Viral Proteins